ReleVote

Modifying Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China

Executive Order Number
14357
President
Donald Trump
Signed
November 4, 2025
Published
November 7, 2025
Source
Federal Register
Original Document
https://www.govinfo.gov/content/pkg/FR-2025-11-07/pdf/2025-19825.pdf

AI-Generated Summary

Purpose

The executive order aims to address the national emergency declared in prior orders regarding the influx of synthetic opioids, including fentanyl, from the People's Republic of China (PRC) to the United States. It reduces previously imposed tariffs on certain Chinese products in response to the PRC's commitments to curb the flow of fentanyl and related chemicals, thereby alleviating the threat to U.S. national security, foreign policy, and economy.

Key Actions or Directives

Significant Changes to Policy or Law

Potential Impacts

Main Stakeholders Affected

Notable Legal, Constitutional, or Political Implications

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.